HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clément Morgat Selected Research

Antigens

5/2023Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers.
4/2023Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R.
1/2023Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II Study.
9/201968Ga-PSMA-617 Compared With 68Ga-RM2 and 18F-FCholine PET/CT for the Initial Staging of High-Risk Prostate Cancer.
6/2019Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Clément Morgat Research Topics

Disease

15Neoplasms (Cancer)
11/2023 - 03/2013
9Prostatic Neoplasms (Prostate Cancer)
04/2024 - 01/2019
4Breast Neoplasms (Breast Cancer)
12/2021 - 01/2017
3Neoplasm Micrometastasis
10/2023 - 01/2016
3Residual Neoplasm
05/2020 - 01/2016
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2017 - 07/2016
1Colonic Neoplasms (Colon Cancer)
01/2023
1Atherosclerosis
05/2021
1Ischemic Stroke
05/2021
1Vascular Diseases (Vascular Disease)
05/2021
1Lymphatic Metastasis
04/2019
1Multiple Endocrine Neoplasia Type 1
07/2016
1Lung Neoplasms (Lung Cancer)
10/2014

Drug/Important Bio-Agent (IBA)

8Radioisotopes (Radionuclides)IBA
11/2023 - 01/2016
7Bombesin Receptors (Bombesin Receptor)IBA
05/2023 - 01/2017
5AntigensIBA
05/2023 - 06/2019
4NeurotensinIBA
12/2021 - 10/2014
3RadiopharmaceuticalsIBA
11/2023 - 01/2016
3LigandsIBA
05/2023 - 01/2017
3BAY 86-7548IBA
01/2023 - 01/2019
3Phenobarbital (Luminal)FDA Link
12/2021 - 01/2017
2Neuropeptide Receptors (Neuropeptide Receptor)IBA
01/2023 - 10/2014
2Peptides (Polypeptides)IBA
03/2020 - 10/2014
2Estrogen ReceptorsIBA
01/2019 - 01/2017
2Peptide Receptors (Peptide Receptor)IBA
01/2017 - 10/2014
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2023
1matrigelIBA
01/2023
1Biological FactorsIBA
12/2021
1ParaffinIBA
05/2021
1Formaldehyde (Formol)FDA Link
05/2021
1Proteins (Proteins, Gene)FDA Link
05/2021
1SiliconIBA
10/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2020
1Choline (Choline Chloride)IBA
09/2019
1Prostate-Specific Antigen (Semenogelase)IBA
09/2019
1Radium-223IBA
01/2019
1abirateroneIBA
01/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2018
1human ERBB2 proteinIBA
01/2017
1Somatostatin Receptors (Somatostatin Receptor)IBA
07/2016
1Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA
10/2014
1BombesinIBA
10/2014

Therapy/Procedure

17Therapeutics
11/2023 - 03/2013
3Prostatectomy (Retropubic Prostatectomy)
04/2024 - 09/2019
2Precision Medicine
04/2023 - 03/2013
1Carotid Endarterectomy
05/2021
1Lymph Node Excision (Lymph Node Dissection)
09/2019
1Neoadjuvant Therapy
01/2017